Zantac
In October 2019, a class-action lawsuit was filed against Sanofi for allegedly misleadingly marketing the over-the-counter heartburn medication Zantac as safe when, according to plaintiffs, the medicine contains dangerously high levels of the carcinogen N-nitrosodimethylamine (NDMA). (Rodriguez et al v. Sanofi U.S. LLC et al, Case No. 19-cv-9527, S. D. NY.)
Class-Action Tracker
The Latest
Adidas: The Greatest Football Story Ever Told
Where there’s a pitch, there’s a legend.
Hike Footwear
Why you may want to walk away from this online retailer.
What You Should Know about Shein
Fast-fashion retailer’s alleged fake discounts are just the beginning.
Michele Oneil/Legacy Builders
What you need to know about this purported money-making opportunity.
Givebutter’s Hidden Fees
How a donation made on this fundraising platform can turn into a costly transaction.